Orchard Therapeutics PLC Sponsored ADR Operating Income 2019-2023 | ORTX
Orchard Therapeutics PLC Sponsored ADR operating income from 2019 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Orchard Therapeutics PLC Sponsored ADR Annual Operating Income (Millions of US $) |
|
|---|---|
| 2022 | $-127 |
| 2021 | $-140 |
| 2020 | $-157 |
| 2019 | $-173 |
| 2018 | $-235 |
| 2017 | $-39 |
| 2016 | $-19 |
| Orchard Therapeutics PLC Sponsored ADR Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2023-09-30 | $-22 |
| 2023-06-30 | $-23 |
| 2023-03-31 | $-26 |
| 2022-12-31 | $-32 |
| 2022-09-30 | $-25 |
| 2022-06-30 | $-32 |
| 2022-03-31 | $-38 |
| 2021-12-31 | $-36 |
| 2021-09-30 | $-33 |
| 2021-06-30 | $-36 |
| 2021-03-31 | $-35 |
| 2020-12-31 | $-39 |
| 2020-09-30 | $-26 |
| 2020-06-30 | $-47 |
| 2020-03-31 | $-45 |
| 2019-12-31 | $-49 |
| 2019-09-30 | $-41 |
| 2019-06-30 | $-54 |
| 2019-03-31 | $-28 |
| 2018-12-31 | $-29 |
| 2018-09-30 | $-34 |
| 2018-06-30 | $-158 |
| 2018-03-31 | $-14 |
